Exploring Sustained Mrd Negativity In Mm With Lenalidomide Maintenance
Let's dive into the details surrounding Sustained Mrd Negativity In Mm With Lenalidomide Maintenance.
- Evangelos Terpos, MD, PhD, University of Athens School of Medicine, Athens, Greece, presents the findings of a study ...
- Furthering our understanding of the mechanisms of disease resistance is an important focus in
- Meletios Dimopoulos, MD, Kapodistrian University of Athens School of Medicine, Athens, Greece, comments on the potential for ...
- Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, FL, discusses the results of a Phase II ...
- Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, talks on the benefits of measurable residual disease (
In-Depth Information on Sustained Mrd Negativity In Mm With Lenalidomide Maintenance
Currently, In this video, Jesús San Miguel, MD, PhD, University of Navarra, Pamplona, Spain, briefly explains the importance of ... The Alexander Lesokhin, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the results of a study that ...
Jesús San Miguel, MD, Universidad de Navarra, Navarra, Spain, discusses the value of
That wraps up our extensive overview of Sustained Mrd Negativity In Mm With Lenalidomide Maintenance.
